S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
S&P 500   4,109.31 (+1.44%)
DOW   33,274.15 (+1.26%)
QQQ   320.93 (+1.66%)
AAPL   164.90 (+1.56%)
MSFT   288.30 (+1.50%)
META   211.94 (+1.97%)
GOOGL   103.73 (+2.81%)
AMZN   103.29 (+1.26%)
TSLA   207.46 (+6.24%)
NVDA   277.77 (+1.44%)
NIO   10.51 (+0.48%)
BABA   102.18 (-1.16%)
AMD   98.01 (+0.13%)
T   19.25 (+0.89%)
F   12.60 (+2.52%)
MU   60.34 (-4.36%)
CGC   1.75 (-0.57%)
GE   95.60 (+1.65%)
DIS   100.13 (+2.07%)
AMC   5.01 (+0.80%)
PFE   40.80 (+1.04%)
PYPL   75.94 (+2.08%)
NFLX   345.48 (+2.08%)
NYSE:DDS

Dillard's - DDS Stock Forecast, Price & News

$307.68
+9.32 (+3.12%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$300.24
$308.56
50-Day Range
$298.36
$415.36
52-Week Range
$193.00
$417.86
Volume
114,521 shs
Average Volume
138,055 shs
Market Capitalization
$5.27 billion
P/E Ratio
6.05
Dividend Yield
0.26%
Price Target
$256.25

Dillard's MarketRank™ Forecast

Analyst Rating
Reduce
1.33 Rating Score
Upside/​Downside
16.7% Downside
$256.25 Price Target
Short Interest
Bearish
14.81% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
-0.15mentions of Dillard
Based on 2 Articles This Week
Insider Trading
Selling Shares
$233,460 Sold Last Quarter
Proj. Earnings Growth
-4.78%
From $33.50 to $31.90 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.45 out of 5 stars

Retail/Wholesale Sector

195th out of 213 stocks

Department Stores Industry

4th out of 4 stocks


DDS stock logo

About Dillard's (NYSE:DDS) Stock

Dillard's, Inc. engages in the retail of fashion apparel, cosmetics, and home furnishings, and other consumer goods. It operates through the Retail Operations and Construction segments. The Retail Operations segment comprises sells cosmetics, ladies' apparel, ladies' accessories and lingerie, juniors' and children's apparel, men's apparel and accessories, shoes, and home and furniture products. The Construction segment constructs and remodels stores through CDI Contractors, LLC. The company was founded by William Thomas Dillard in 1938 and is headquartered in Little Rock, AR.

Receive DDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dillard's and its competitors with MarketBeat's FREE daily newsletter.

DDS Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Dillard’s Launches Venita Aspen for Gianni Bini
Why Dillard's Stock Dropped 12.3% This Week
Dillard's (DDS) Q4 Earnings and Revenues Beat Estimates
Dillard’s Launches Jennifer Sumko for Antonio Melani
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
5 Stocks to Pop Surprise Returns From Secret Santa
3 Retail Stocks Primed for a Santa Claus Rally
Here's Why it is Apt to Buy Dillard's (DDS) at This Moment
Dillard's Third Quarter 2023 Earnings: Beats Expectations
See More Headlines
Receive DDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dillard's and its competitors with MarketBeat's FREE daily newsletter.

DDS Company Calendar

Last Earnings
11/11/2021
Ex-Dividend for 1/30 Dividend
12/29/2022
Dividend Payable
1/30/2023
Ex-Dividend for 5/1 Dividend
3/30/2023
Today
3/31/2023
Dividend Payable
5/01/2023
Next Earnings (Estimated)
5/11/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Department stores
Sub-Industry
Department Stores
CUSIP
25406710
Employees
30,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$256.25
High Stock Price Forecast
$380.00
Low Stock Price Forecast
$150.00
Forecasted Upside/Downside
-16.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.33
Research Coverage
3 Analysts

Profitability

Net Income
$891.60 million
Pretax Margin
15.86%

Debt

Sales & Book Value

Annual Sales
$6.87 billion
Cash Flow
$62.16 per share
Book Value
$93.35 per share

Miscellaneous

Free Float
12,022,000
Market Cap
$5.27 billion
Optionable
Optionable
Beta
0.94

Key Executives

  • William Thomas Dillard
    Chairman & Chief Executive Officer
  • Alex Dillard
    President & Director
  • Phillip R. Watts
    Senior VP, Co-Chief Financial & Accounting Officer
  • Chris B. Johnson
    Co-Chief Financial Officer & Senior VP
  • Tony Bolte
    Vice President-Information Technology & Logistics













DDS Stock - Frequently Asked Questions

Should I buy or sell Dillard's stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dillard's in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" DDS shares.
View DDS analyst ratings
or view top-rated stocks.

What is Dillard's' stock price forecast for 2023?

3 equities research analysts have issued 1 year target prices for Dillard's' stock. Their DDS share price forecasts range from $150.00 to $380.00. On average, they expect the company's stock price to reach $256.25 in the next year. This suggests that the stock has a possible downside of 15.7%.
View analysts price targets for DDS
or view top-rated stocks among Wall Street analysts.

How have DDS shares performed in 2023?

Dillard's' stock was trading at $323.20 on January 1st, 2023. Since then, DDS stock has decreased by 5.9% and is now trading at $304.13.
View the best growth stocks for 2023 here
.

Are investors shorting Dillard's?

Dillard's saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 1,360,000 shares, a decrease of 5.6% from the February 13th total of 1,440,000 shares. Based on an average trading volume of 132,400 shares, the days-to-cover ratio is currently 10.3 days. Approximately 15.2% of the shares of the stock are short sold.
View Dillard's' Short Interest
.

When is Dillard's' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our DDS earnings forecast
.

How were Dillard's' earnings last quarter?

Dillard's, Inc. (NYSE:DDS) issued its quarterly earnings data on Thursday, November, 11th. The company reported $9.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.52 by $4.29. The firm had revenue of $1.48 billion for the quarter, compared to analysts' expectations of $1.27 billion. Dillard's had a net margin of 12.98% and a trailing twelve-month return on equity of 54.80%.

How often does Dillard's pay dividends? What is the dividend yield for Dillard's?

Dillard's declared a quarterly dividend on Thursday, February 23rd. Investors of record on Friday, March 31st will be given a dividend of $0.20 per share on Monday, May 1st. This represents a $0.80 dividend on an annualized basis and a yield of 0.26%. The ex-dividend date is Thursday, March 30th.
Read our dividend analysis for DDS
.

Is Dillard's a good dividend stock?

Dillard's (NYSE:DDS) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.27%. The dividend payout ratio is 1.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DDS will have a dividend payout ratio of 2.51% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DDS.

What is Bill Dillard II's approval rating as Dillard's' CEO?

2,306 employees have rated Dillard's Chief Executive Officer Bill Dillard II on Glassdoor.com. Bill Dillard II has an approval rating of 46% among the company's employees. This puts Bill Dillard II in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Dillard's own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dillard's investors own include Intel (INTC), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), CVS Health (CVS), General Electric (GE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Hawkins (HWKN).

What is Dillard's' stock symbol?

Dillard's trades on the New York Stock Exchange (NYSE) under the ticker symbol "DDS."

Who are Dillard's' major shareholders?

Dillard's' stock is owned by a variety of retail and institutional investors. Top institutional investors include Newport Trust Co (30.15%), Dimensional Fund Advisors LP (5.63%), Wedge Capital Management L L P NC (0.65%), Morgan Stanley (0.53%), Alyeska Investment Group L.P. (0.51%) and Millennium Management LLC (0.43%). Insiders that own company stock include Chris B Johnson, Dean L Worley, Drue Matheny, J C Watts Jr, James I Freeman, James I Freeman, Mike Litchford, Reynie Rutledge, Tom W Bolin, Tony J Bolte and Warren A Stephens.
View institutional ownership trends
.

How do I buy shares of Dillard's?

Shares of DDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Dillard's' stock price today?

One share of DDS stock can currently be purchased for approximately $304.13.

How much money does Dillard's make?

Dillard's (NYSE:DDS) has a market capitalization of $5.21 billion and generates $6.87 billion in revenue each year. The company earns $891.60 million in net income (profit) each year or $50.83 on an earnings per share basis.

How many employees does Dillard's have?

The company employs 30,500 workers across the globe.

How can I contact Dillard's?

Dillard's' mailing address is 1600 CANTRELL ROAD, LITTLE ROCK AR, 72201. The official website for the company is www.dillards.com. The company can be reached via phone at (501) 376-5200, via email at julie.bull@dillards.com, or via fax at 501-376-5917.

This page (NYSE:DDS) was last updated on 3/31/2023 by MarketBeat.com Staff